FAST
46
-3
HIG
51
3
WFC
58
-2
FMC
37
-2
NWL
62
-3
JNJ
36
3
FDX
34
-2
VZ
39
2
NWS
52
-4
HST
58
-4
JBHT
53
-3
PLD
43
-2
NDAQ
50
-6
CHRW
51
-6
PBI
59
-7
HAS
32
-5
CSCO
61
-3
AAPL
64
11
AN
50
-5
T
48
3
FAST
46
-3
HIG
51
3
WFC
58
-2
FMC
37
-2
NWL
62
-3
JNJ
36
3
FDX
34
-2
VZ
39
2
NWS
52
-4
HST
58
-4
JBHT
53
-3
PLD
43
-2
NDAQ
50
-6
CHRW
51
-6
PBI
59
-7
HAS
32
-5
CSCO
61
-3
AAPL
64
11
AN
50
-5
T
48
3
Financhill
Back

Tele2 AB Vs. NovoCure Industry Stock Comparison

Buy
51

TLTZF
Tele2 AB

Last Price:
11.50
Seasonality Move:
0.25%
Buy
75

NVCR
NovoCure

Last Price:
33.40
Seasonality Move:
-5.24%
Buy
51
Tele2 AB (TLTZF) is a Buy

Is Tele2 AB a Buy, Sell or Hold?

  • The current Tele2 AB [TLTZF] share price is $11.50. The Score for TLTZF is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • TLTZF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
NovoCure (NVCR) is a Buy

Is NovoCure a Buy, Sell or Hold?

  • The current NovoCure [NVCR] share price is $33.41. The Score for NVCR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

TLTZF Stock Price Chart

What is Tele2 AB's stock price today?

  • The Tele2 AB share price today is $11.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TLTZF is experiencing slight buying pressure.

NVCR Stock Price Chart

What is NovoCure's stock price today?

  • The NovoCure share price today is $33.41
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

TLTZF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 99.92 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.5 - 11.5) Sell
Bollinger Bands (100): (10.5 - 11.72) Buy

NVCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.78 Buy
Relative Strength Index (14 RSI): 75.34 Buy
Chaikin Money Flow: 1118573 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.36 - 28.56) Buy
Bollinger Bands (100): (14.7 - 22.78) Buy

TLTZF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.5 Sell
20-day SMA: 11.5 Sell
50-day SMA: 11.5 Sell
200-day SMA: 10.14 Buy
8-day EMA: 11.5 Buy
20-day EMA: 11.5 Buy
50-day EMA: 11.41 Buy
200-day EMA: 10.45 Buy

NVCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.6 Buy
20-day SMA: 23.68 Buy
50-day SMA: 19.33 Buy
200-day SMA: 17.9 Buy
8-day EMA: 29.53 Buy
20-day EMA: 25.45 Buy
50-day EMA: 21.38 Buy
200-day EMA: 19.88 Buy

Tele2 AB Earnings Growth & TLTZF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

NovoCure Earnings Growth & NVCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.31 per share.

Tele2 AB Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovoCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):